Hazlehurst, Lori A.

Role of the tumor microenvironment in mediating de novo resistance to drugs and physiological mediators of cell death

Hazlehurst, L. A., Landowski, T. H., & Dalton, W. S. (2003) · Oncogene

Cancer Cells and MetastasisCell death mechanisms and regulation

Cited by 203

Stat3 contributes to resistance toward BCR-ABL inhibitors in a bone marrow microenvironment model of drug resistance

Bewry, N. N., Nair, R. R., Emmons, M. F., Boulware, D., Pinilla-Ibarz, J., & Hazlehurst, L. A. (2008) · Molecular Cancer Therapeutics

Chronic Myeloid Leukemia TreatmentsProtein Tyrosine Phosphatases

Cited by 150

Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling

Wang, L., Yi, W., Ma, L., Lecea, E., Hazlehurst, L. A., Adjeroh, D. A., & Hu, G. (2023) · Cancers

Multiple Myeloma Research and TreatmentsMesenchymal stem cell research

Cited by 17